4CPS-139 Study assessing the use of high-cost off-label drugs in the treatment of atopic dermatitis

BACKGROUND: After several years without new drugs for atopic dermatitis, some clinical trials with monoclonal antibodies are underway. We have found it interesting to review the health results of the high cost of off-label drugs used until now, in patients refractory to available treatments. PURPOSE...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Hosp Pharm
Autori principali: Torres, P Pelegrin, de Gorostiza, C, Bécares, FJ, Martin, EM, García, L, Hernandez, M, Arias, MA
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2018
Soggetti:
Section 4: Clinical pharmacy services
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535238/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.230
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi